Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cidara Therapeutics, Inc. | COO & CLO | Common Stock | 319K | $220K | $0.69 | Mar 15, 2024 | Direct |
Cidara Therapeutics, Inc. | COO & CLO | Employee Stock Option (right to buy) | 250K | Mar 15, 2024 | Direct | ||
Cidara Therapeutics, Inc. | COO & CLO | Employee Stock Option (right to buy) | 136K | Sep 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDTX | Cidara Therapeutics, Inc. | Sep 30, 2024 | 1 | $0 | 4 | Oct 2, 2024 | COO & CLO |
CDTX | Cidara Therapeutics, Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 20, 2024 | COO & CLO |
CDTX | Cidara Therapeutics, Inc. | Mar 11, 2024 | 1 | -$13.7K | 4 | Mar 12, 2024 | COO & CLO |
CDTX | Cidara Therapeutics, Inc. | Mar 27, 2023 | 2 | $0 | 4 | Mar 29, 2023 | COO & CLO |
CDTX | Cidara Therapeutics, Inc. | Mar 13, 2023 | 1 | -$6.62K | 4 | Mar 13, 2023 | COO & CLO |
CDTX | Cidara Therapeutics, Inc. | Mar 31, 2022 | 4 | -$19.2K | 4 | Apr 4, 2022 | CHIEF LEGAL OFFICER |
CDTX | Cidara Therapeutics, Inc. | Aug 25, 2021 | 1 | $0 | 4 | Aug 27, 2021 | CHIEF LEGAL OFFICER |
CDTX | Cidara Therapeutics, Inc. | Aug 25, 2021 | 0 | $0 | 3 | Aug 27, 2021 | CHIEF LEGAL OFFICER |